We undertook a high-throughput ChIP-sequencing study of IRF1 chromatin bound regions in unstimulated and IFN-gamma stimulated breast cancer cells in order to increase our understanding of pathways regulated by IRF1 in cells. The gene discussed is IFNG; the disease is breast cancer.